Inventiva SA (IVA)
3.45
+0.06
(+1.77%)
USD |
NASDAQ |
Nov 19, 16:00
3.42
-0.03
(-0.87%)
Pre-Market: 08:18
Inventiva Enterprise Value : 763.78M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 763.78M |
| November 18, 2026 | 749.60M |
| November 17, 2026 | 709.43M |
| November 16, 2026 | 733.06M |
| November 13, 2026 | 818.12M |
| November 12, 2026 | 865.38M |
| November 11, 2026 | 896.09M |
| November 10, 2026 | 881.92M |
| November 09, 2026 | 855.93M |
| November 06, 2026 | 846.48M |
| November 05, 2026 | 806.31M |
| November 04, 2026 | 863.01M |
| November 03, 2026 | 900.82M |
| November 02, 2026 | 853.56M |
| October 30, 2026 | 811.03M |
| October 29, 2026 | 829.94M |
| October 28, 2026 | 825.21M |
| October 27, 2026 | 819.30M |
| October 26, 2026 | 813.40M |
| October 23, 2026 | 825.21M |
| October 22, 2026 | 799.22M |
| October 21, 2026 | 787.40M |
| October 20, 2026 | 718.88M |
| October 19, 2026 | 652.73M |
| October 16, 2026 | 643.27M |
| Date | Value |
|---|---|
| October 15, 2026 | 683.44M |
| October 14, 2026 | 626.73M |
| October 13, 2026 | 626.73M |
| October 12, 2026 | 685.80M |
| October 09, 2026 | 695.26M |
| October 08, 2026 | 733.06M |
| October 07, 2026 | 743.69M |
| October 06, 2026 | 766.14M |
| October 05, 2026 | 770.87M |
| October 02, 2026 | 789.77M |
| October 01, 2026 | 766.14M |
| September 30, 2026 | 820.48M |
| September 29, 2026 | 725.97M |
| September 28, 2026 | 782.68M |
| September 25, 2026 | 744.87M |
| September 24, 2026 | 718.88M |
| September 23, 2026 | 763.78M |
| September 22, 2026 | 811.03M |
| September 21, 2026 | 811.03M |
| September 18, 2026 | 841.75M |
| September 17, 2026 | 834.66M |
| September 16, 2026 | 844.11M |
| September 15, 2026 | 860.65M |
| September 14, 2026 | 865.38M |
| September 11, 2026 | 898.46M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 448.46M |
| Cellectis SA | 36.50M |
| Genfit SA | -- |
| Innate Pharma SA | -- |
Enterprise Value Related Metrics
| Earnings Yield | -39.77% |
| Normalized Earnings Yield | -29.12 |